Yellow Fever
National Organization for Rare Disorders, Inc.
Synonyms
Disorder Subdivisions
General Discussion
Yellow Fever is a viral infection that causes damage to the liver, kidney, heart and gastrointestinal tract. Major symptoms may include sudden onset of fever, yellowing of the skin (jaundice) and hemorrhage. It occurs predominately in South America, the Caribbean Islands and Africa. The disease is spread through bites of infected mosquitos. Incidence of the disease tends to increase in the summer as the mosquito population increases, and it occurs year round in tropical climates.
Yellow Fever has two cycles: the sylvan cycle in which mosquitos primarily spread the disease among forest-dwelling primates, and the urban cycle in which the infection is spread from human to human.
Symptoms
The symptoms of Yellow Fever are the sudden onset of fever and chills along with headache, backache, generalized pain, nausea, vomiting, flushed face and infection of the inner eyelid. The fever usually disappears after three days, reappearing several days later with new symptoms of jaundice, bleeding gums, soft palate hemorrhages, and the vomiting of blood (black vomit). The patient may go into shock during this phase.
Yellow Fever may also appear in a mild form with symptoms resembling influenza, malaria, dengue fever or typhoid. In this case, the fever usually lasts less than one week. .
Causes
Yellow Fever is caused by a virus spread by the bite by an infected mosquito. Initially, a mosquito acquires the disease by ingesting the blood of an infected host. The mosquito then transmits the infection to its next bite victim.
Affected Populations
Yellow Fever affects males and females equally. People living in semitropical or tropical climates are at risk unless they are vaccinated against this infection. People in southern areas of the United States, living near marshes and swamps may be at risk during the summer months. However, most cases of Yellow Fever occur in Africa and South America. .
Related Disorders
Symptoms of the following disorders can be similar to those of Yellow Fever. Comparisons may be useful for a differential diagnosis:
Dengue Fever is a disease also transmitted by a mosquito bite and characterized by a skin rash and a high fever with severe pain in the head and muscles. There is a sudden onset of symptoms with pain also occuring in the lower back, legs and joints. (For more information on this disorder, choose "Dengue Fever" as your search term in the Rare Disease Database.)
Viral Encephalitis is a disease characterized by fever, headache, vomiting, rigidity of the neck, lethargy and convulsions. Generalized muscular weakness and paralysis may also occur.
Malaria is a communicable disorder also spread through the bite of a mosquito. Symptoms include chills and fever, although not every case follows the same pattern. Symptoms may begin a week after exposure to the mosquito or months later. (For more information of this disorder, choose "Malaria" as your search term in the Rare Disease Database.)
Standard Therapies
The treatment of Yellow Fever is symptomatic and supportive. Preventative measures consist of mosquito control and a vaccine that prevents development of the infection. Immunity from a vaccination usually develops after 10 days and lasts for more than 10 years. In some cases, side effects associated with vaccination may occur five to 10 days later. These side effects affect approximately 5 percent of individuals receiving immunization and may include headache, fever, and/or aching muscles. .
Investigational Therapies
A pharmaceutical company known as Genelabs Technologies, Inc., is working on an RNA-binding drug program that has produced several compounds that potentially inhibit viral activity. It is hoped that this might lead to drug treatment options for RNA viruses including yellow fever, hepatitis C, Japanese Encephalitis, and Dengue fever. More research is necessary to develop and test such drugs for safety and long-term effectiveness. .
References
INTERNAL MEDICINE, 2nd Ed.: Jay H. Stein, ed.-in-chief; Little, Brown and Co., 1987. Pp. 1594-1599.
THE MERCK MANUAL, Volume 1, 14th Ed.: Robert Berkow, M.D. ed.-in chief; Merck, Sharp & Dohme Laboratories., 1982. Pp. 120.
JOURNAL ARTICLES Fournier-Caruana J, et al., In vitro potency assay for yellow fever vaccines: comparison of three vero cell lines sources. Biologicals. 2000;28:33-40.
Perraut R, et al., Stability-related studies on 17D yellow fever vaccine. Microbes Infect. 2000;2:33-8.
Tomori O, Impact of yellow fever on the developing world. Adv Virus Res. 1999;53:5-34.
Monath TO, Yellow fever: a medically neglected disease. Report on a seminar. Rev Infect Dis. 1987;9:165-75.
de Souza Lopes O, et al., Studies on yellow fever vaccine. I. Quality control parameters. J Biol Stand. 1987;159:323-9.
Resources
Centers for Disease Control and Prevention
1600 Clifton Road NE Atlanta, GA 30333 Tel: (404)639-3534 Tel: (800)311-3435 Email: http://www.cdc.gov/netinfo.htm Internet: http://www.cdc.gov/
NIH/National Institute of Allergy and Infectious Diseases
6610 Rockledge Drive MSC 6612 Bethesda, MD 20892-6612 Tel: (301)496-5717 Fax: (301)402-3573 TDD: (800)877-8339 Internet: http://www.niaid.nih.gov/
World Health Organization (WHO) Regional Office for the Americas (AMRO)
Pan American Health Organization (PAHO) 525 23rd Street NW Washington, DC 20037 Tel: (202)974-3000 Fax: (202)974-3663 Email: postmaster@paho.org Internet: http://www.who.ch/
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for
informational purposes only. NORD recommends that affected individuals seek the advice or counsel of
their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms
listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the
topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease
Database completely current and accurate. Please check with the agencies listed in the Resources section
for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization
for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site
www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 8/29/2000
Copyright 1990, 2000
National Organization for Rare Disorders, Inc.
|
|
|
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|